These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 8264912)
1. Neuropsychological and psychiatric side effects in the treatment of Parkinson's disease. Saint-Cyr JA; Taylor AE; Lang AE Neurology; 1993 Dec; 43(12 Suppl 6):S47-52. PubMed ID: 8264912 [TBL] [Abstract][Full Text] [Related]
2. [Psychiatric complications of L-dopa: physiopathology and treatment]. Castro-García A Rev Neurol; 1997 Aug; 25 Suppl 2():S157-62. PubMed ID: 9280683 [TBL] [Abstract][Full Text] [Related]
3. Complications of disease and therapy: a comparison of younger and older patients with Parkinson's disease. Wagner ML; Fedak MN; Sage JI; Mark MH Ann Clin Lab Sci; 1996; 26(5):389-95. PubMed ID: 8879356 [TBL] [Abstract][Full Text] [Related]
6. [The mental state of parkinsonian patients]. Dubois B Rev Prat; 1989 Mar; 39(8):658-61. PubMed ID: 2727573 [TBL] [Abstract][Full Text] [Related]
7. Treatment options for early Parkinson's disease. Stacy M; Brownlee HJ Am Fam Physician; 1996 Mar; 53(4):1281-7. PubMed ID: 8629572 [TBL] [Abstract][Full Text] [Related]
8. Selegiline: a second look. Six years later: too risky in Parkinson's disease. Prescrire Int; 2002 Aug; 11(60):108-11. PubMed ID: 12199263 [TBL] [Abstract][Full Text] [Related]
9. [Emotional and cognitive disorders in Parkinson disease]. Arsland D; Larsen JP Tidsskr Nor Laegeforen; 1998 Oct; 118(25):3959-63. PubMed ID: 9830342 [TBL] [Abstract][Full Text] [Related]
10. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia. Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733 [TBL] [Abstract][Full Text] [Related]
11. [Drug treatment is beneficial also for elderly patients with Parkinson disease. Important to consider also other co-existing diseases]. Granérus AK Lakartidningen; 2001 Mar; 98(13):1515-23. PubMed ID: 11330147 [TBL] [Abstract][Full Text] [Related]
12. Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease. Devos D; Mov Disord; 2009 May; 24(7):993-1000. PubMed ID: 19253412 [TBL] [Abstract][Full Text] [Related]
13. Drug therapy for Parkinson's disease. Hermanowicz N Semin Neurol; 2007 Apr; 27(2):97-105. PubMed ID: 17390254 [TBL] [Abstract][Full Text] [Related]
14. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614 [TBL] [Abstract][Full Text] [Related]